BMO Capital Upgrades Kindred Biosciences (KIN) to Speculative Outperform
Tweet Send to a Friend
BMO Capital upgraded Kindred Biosciences (NASDAQ: KIN) from Market Perform to Speculative ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
